Logo image of HCDI

HARBOR CUSTOM DEVELOPMENT (HCDI) Stock Fundamental Analysis

NASDAQ:HCDI - Nasdaq - US41150T3068 - Common Stock - Currency: USD

0.199  -0.12 (-37.62%)

After market: 0.1503 -0.05 (-24.47%)

Fundamental Rating

1

Overall HCDI gets a fundamental rating of 1 out of 10. We evaluated HCDI against 64 industry peers in the Household Durables industry. HCDI may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, HCDI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

HCDI had negative earnings in the past year.
In the past year HCDI has reported a negative cash flow from operations.
In multiple years HCDI reported negative net income over the last 5 years.
HCDI had negative operating cash flow in 4 of the past 5 years.
HCDI Yearly Net Income VS EBIT VS OCF VS FCFHCDI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 0 -20M -40M -60M -80M

1.2 Ratios

Looking at the Return On Assets, with a value of -20.44%, HCDI is doing worse than 86.96% of the companies in the same industry.
With a Return On Equity value of -88.89%, HCDI is not doing good in the industry: 86.96% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -20.44%
ROE -88.89%
ROIC N/A
ROA(3y)-5.78%
ROA(5y)-4.62%
ROE(3y)-24.14%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HCDI Yearly ROA, ROE, ROICHCDI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 0 -200 -400 -600

1.3 Margins

HCDI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HCDI Yearly Profit, Operating, Gross MarginsHCDI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 20 -20 -40

More info and screens

0

2. Health

2.1 Basic Checks

HCDI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HCDI remains at a similar level compared to 1 year ago.
HCDI has a worse debt/assets ratio than last year.
HCDI Yearly Shares OutstandingHCDI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 200K 400K 600K
HCDI Yearly Total Debt VS Total AssetsHCDI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -1.41, we must say that HCDI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of HCDI (-1.41) is worse than 92.75% of its industry peers.
HCDI has a Debt/Equity ratio of 3.03. This is a high value indicating a heavy dependency on external financing.
HCDI has a Debt to Equity ratio of 3.03. This is amonst the worse of the industry: HCDI underperforms 89.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.03
Debt/FCF N/A
Altman-Z -1.41
ROIC/WACCN/A
WACC7.32%
HCDI Yearly LT Debt VS Equity VS FCFHCDI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 50M -50M 100M

2.3 Liquidity

A Current Ratio of 0.06 indicates that HCDI may have some problems paying its short term obligations.
HCDI's Current ratio of 0.06 is on the low side compared to the rest of the industry. HCDI is outperformed by 97.10% of its industry peers.
A Quick Ratio of 0.06 indicates that HCDI may have some problems paying its short term obligations.
The Quick ratio of HCDI (0.06) is worse than 97.10% of its industry peers.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
HCDI Yearly Current Assets VS Current LiabilitesHCDI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

HCDI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -173.10%.
The Revenue for HCDI has decreased by -48.86% in the past year. This is quite bad
The Revenue has been growing by 43.24% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-173.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1.49%
Revenue 1Y (TTM)-48.86%
Revenue growth 3Y21.43%
Revenue growth 5Y43.24%
Sales Q2Q%-52.85%

3.2 Future

HCDI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.36% yearly.
HCDI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 43.55% yearly.
EPS Next Y67.92%
EPS Next 2Y39.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year123.52%
Revenue Next 2Y43.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
HCDI Yearly Revenue VS EstimatesHCDI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
HCDI Yearly EPS VS EstimatesHCDI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 0 -10 -20 -30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HCDI. In the last year negative earnings were reported.
Also next year HCDI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HCDI Price Earnings VS Forward Price EarningsHCDI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HCDI Per share dataHCDI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20

4.3 Compensation for Growth

A more expensive valuation may be justified as HCDI's earnings are expected to grow with 39.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.36%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HCDI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HARBOR CUSTOM DEVELOPMENT

NASDAQ:HCDI (12/20/2023, 8:15:24 PM)

After market: 0.1503 -0.05 (-24.47%)

0.199

-0.12 (-37.62%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)11-14 2023-11-14/amc
Earnings (Next)03-29 2024-03-29/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners12.77%
Ins Owner Change0%
Market Cap457.70K
Analysts82.86
Price Target6.12 (2975.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend11.14
Dividend Growth(5Y)N/A
DP-5.55%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3505.36%
Min EPS beat(2)-5408.12%
Max EPS beat(2)-1602.6%
EPS beat(4)0
Avg EPS beat(4)-1875.24%
Min EPS beat(4)-5408.12%
Max EPS beat(4)-68.61%
EPS beat(8)1
Avg EPS beat(8)-1570.56%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-63.9%
Min Revenue beat(2)-84.35%
Max Revenue beat(2)-43.46%
Revenue beat(4)0
Avg Revenue beat(4)-53.71%
Min Revenue beat(4)-84.35%
Max Revenue beat(4)-24.37%
Revenue beat(8)1
Avg Revenue beat(8)-39.66%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B 0.01
P/tB 0.01
EV/EBITDA N/A
EPS(TTM)-38.78
EYN/A
EPS(NY)-2.04
Fwd EYN/A
FCF(TTM)-20.81
FCFYN/A
OCF(TTM)-20.44
OCFYN/A
SpS17.11
BVpS22.39
TBVpS22.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.44%
ROE -88.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.78%
ROA(5y)-4.62%
ROE(3y)-24.14%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 3.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 129.23%
Cap/Sales 2.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z -1.41
F-Score1
WACC7.32%
ROIC/WACCN/A
Cap/Depr(3y)107.84%
Cap/Depr(5y)131.88%
Cap/Sales(3y)2.21%
Cap/Sales(5y)3.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-173.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1.49%
EPS Next Y67.92%
EPS Next 2Y39.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-48.86%
Revenue growth 3Y21.43%
Revenue growth 5Y43.24%
Sales Q2Q%-52.85%
Revenue Next Year123.52%
Revenue Next 2Y43.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-25025%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year12826.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y28.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.49%
OCF growth 3YN/A
OCF growth 5YN/A